Digital Health
The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.
The Series E funding comes four months after the company secured $250 million in a Series D round.
HIMSS25
AI tools can personalize patients' searches for providers, but Kyruus Health's Gen Conlin believes nurse informaticists' ability to ensure tool accessibility and accuracy are vital to ensuring patients find the right care.
Selected early versions will be slated for real-world deployment.
The partnership has been terminated less than two months after launch as Novo Nordisk alleges Hims & Hers is illegally selling copycat drugs and using deceptive marketing practices.
Julien Payen, cofounder and CEO of Lattice Medical, discusses the company’s 3D-printed breast implant that supports women recovering from mastectomy using a scaffold that gradually dissolves as the patient’s own tissue regenerates.
HIMSS25
Dr. Sarah Hoffe, interim GI oncology chair at Moffitt Cancer Center, says telemedicine platforms and other technologies help ease nurse burnout, boost patient adherence and enable focused, personalized patient connections.
Funding from the venture capital firm's Customer Value Fund will allow Commure to accelerate its expansion in healthcare without ownership dilution.
The funding comes on the heels of the fax automation company's $37 million Series B funding round and $18 million Series A raise last year.
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.